HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (32) Citing Articles via Google Scholar Google Scholar Articles by Pistolesi, M. Articles by Rusthoven, J. Search for Related Content PubMed PubMed Citation Articles by Pistolesi, M. Articles by Rusthoven, J.

Malignant Pleural Mesothelioma^*

Update, Current Management, and Newer Therapeutic Strategies

^* From the Department of Medicine (Dr. Rusthoven), McMaster University, Hamilton, ON, Canada; and Department of Critical Care (Dr. Pistolesi), University of Florence, Firenze, Italy.

Correspondence to: Massimo Pistolesi, MD, Section of Respiratory Medicine, Department of Critical Care, University of Florence, Viale G.B. Morgagni 85, 50134 Firenze, Italy; e-mail: massimo{at}unifi.it

The diagnosis and management of malignant pleural mesothelioma are major challenges that often frustrate both patient and clinician alike. Occupational asbestos exposure to crocidolite or amosite forms of the fiber is the most important known risk factor in North America and Western Europe. Other mineral fibers such as erionite, a naturally occurring fibrous zeolite crystal, are associated with mesothelioma in volcanic tuffs of the Cappadocia region of central Anatolia in Turkey. In addition, other possible factors such as the presence of simian virus 40 and genetic susceptibility have been associated recently with the development of mesothelioma in animal models. These latter findings are increasing our understanding of this disease. In addition, the discovery of elevated levels of various markers such as folic acid receptor , cyclooxygenase 2, and multidrug resistance proteins 1 and 2 in mesothelioma tissue have opened up new areas of potential diagnostic and therapeutic importance. However, traditional treatment modalities—surgery, radiotherapy, and chemotherapy—have evolved slowly, and few gains in therapeutic efficacy have occurred. Recently, however, continuing research efforts have led to novel treatment strategies that are changing the way clinicians view a disease that has traditionally been managed with almost universal therapeutic nihilism. This review explores our current knowledge of this disease and presents current and novel therapeutic strategies.

Key Words: chemotherapy • epidemiology • gemcitabine • mesothelioma • pathogenesis • pemetrexed • treatment

This article has been cited by other articles:

				M. Louis, J. Gruber, and R. Fraser A CASE OF A PLEURAL EFFUSION, CALCIFIED PLEURAL PLAQUES AND AN ABNORMAL BONE SCAN Chest Meeting Abstracts, October 1, 2005; 128(4): 431S - 431S. [Abstract] [Full Text] [PDF]

				E. Anton and M. Pistolesi Malignant Pleural Mesothelioma With Less-Frequent Features Chest, August 1, 2005; 128(2): 1068 - 1068. [Full Text] [PDF]

				M. E. Ramos-Nino, G. Vianale, T. Sabo-Attwood, L. Mutti, C. Porta, N. Heintz, and B. T. Mossman Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase Mol. Cancer Ther., May 1, 2005; 4(5): 835 - 842. [Abstract] [Full Text] [PDF]